Valuation: CStone Pharmaceuticals

Market Cap 6.46B 7.48B 954M 836M 773M 711M 1.34B 91.99B 1.36B 9.24B 3.62B 45.01B 3.58B 3.5B 155B P/E 2026 *
-303x
P/E 2027 * 6.03x
Enterprise Value 5.93B 6.87B 876M 768M 710M 653M 1.23B 84.47B 1.25B 8.49B 3.33B 41.33B 3.29B 3.22B 142B EV / Sales 2026 *
12.4x
EV / Sales 2027 * 1.67x
Free-Float
77.71%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: CStone Pharmaceuticals

1 day+3.31%
1 week-11.36%
Current month-0.64%
1 month+1.08%
3 months-53.66%
6 months-18.89%
Current year-11.20%
1 week 4.5
Extreme 4.5
5.37
1 month 4.25
Extreme 4.25
5.79
Current year 4.01
Extreme 4.01
10.41
1 year 4.01
Extreme 4.01
13.15
3 years 0.8
Extreme 0.8
13.15
5 years 0.8
Extreme 0.8
17.54
10 years 0.8
Extreme 0.8
19.12
Manager TitleAgeSince
Chief Executive Officer 62 2022-08-24
Director of Finance/CFO - 2023-01-17
Chief Operating Officer 46 2016-07-31
Director TitleAgeSince
Chairman 55 -
Director/Board Member 62 2022-08-24
Director/Board Member 63 2021-07-08
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Other

Chief Executive Officer

331,000 0.0207%
6/23/26 Other

Chief Executive Officer

11,270,000 0.7043%
6/12/26 Other

Chief Executive Officer

200,000 0.0125%
Change 5-day change 1-year change 3-year change Capi.($)
+3.31%-11.36%-28.77%+89.47% 923M
+0.50%+2.40%+24.47%-6.09% 68.85B
-0.54%+1.02%+37.33%+189.96% 52.13B
-3.65%+34.50%+34.50%+34.50% 43.46B
-0.58%-0.23%-52.36%-53.82% 41.24B
-1.49%-3.09%+65.13%-26.25% 30.41B
-0.68%-8.42%+98.16%-50.81% 24.53B
-1.21%+1.14%+71.46%+80.49% 23.42B
+3.99%+3.12%+3.87%+200.81% 19.75B
+0.26%+0.39%+72.12%+126.52% 16.57B
Average +0.02%-2.34%+32.59%+58.48% 32.13B
Weighted average by Cap. -0.55%-0.50%+31.99%+45.91%

Financials

2026 *2027 *
Net sales 479M 555M 70.78M 62.04M 57.35M 52.74M 99.52M 6.83B 101M 686M 269M 3.34B 266M 260M 11.51B 1.71B 1.98B 253M 222M 205M 189M 356M 24.4B 361M 2.45B 961M 11.94B 950M 929M 41.13B
Net income -243M -282M -35.92M -31.48M -29.1M -26.76M -50.49M -3.46B -51.3M -348M -136M -1.69B -135M -132M -5.84B 687M 796M 102M 88.98M 82.25M 75.65M 143M 9.79B 145M 983M 386M 4.79B 381M 373M 16.5B
Net Debt -528M -612M -78M -68.37M -63.2M -58.12M -110M -7.52B -111M -756M -296M -3.68B -293M -287M -12.68B -3.6B -4.17B -532M -466M -431M -396M -748M -51.31B -760M -5.15B -2.02B -25.11B -2B -1.95B -86.5B
Logo CStone Pharmaceuticals
CStone Pharmaceuticals is an investment holding company primarily engaged in research and development of therapies for oncology, autoimmune and inflammation, and other key disease areas. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The Company is also engaged in the development and commercialization of immuno-oncology. The Company primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.
Employees
136
Date Price Change Volume
26-07-20 HK$4.680 +3.31% 10,171,000
26-07-17 HK$4.530 -12.55% 12,204,000
26-07-16 HK$5.180 +0.19% 5,882,500
26-07-15 HK$5.170 +5.08% 7,980,270
26-07-14 HK$4.920 -0.61% 4,395,700
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.916CNY
Average target price
12.38CNY
Spread / Average Target
+216.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2616 Stock